![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Manuscript received 30 August 1996. Initial reviews completed 9 October 1996. Revision accepted 14 November 1996.
Discipline of Nutrition and Dietetics, University of Newcastle, Callaghan, NSW 2308, Australia, * Department of Cardiology and ** Discipline of Reproductive Medicine, John Hunter Hospital, NSW 2308, Australia
The role of marine fish oil (n-3) polyunsaturated fatty acids in the prevention of fatal ventricular arrhythmia has been established in experimental animals. Prevention of arrhythmias arising at the onset of ischemia and reperfusion is important because if untreated, they result in sudden cardiac death. Animals supplemented with fish oils in their diet developed little or no ventricular fibrillation after ischemia was induced. Similar effects have also been observed in cultured neonatal cardiomyocytes. Several mechanisms have been proposed and studied to explain the antiarrhythmic effects of fish oil polyunsaturated fatty acids, but to date, no definite mechanism has been validated. The sequence of action of these mechanisms and whether more than one mechanism is involved is also not clear. Some of the mechanisms suggested to explain the antiarrhythmic action of fish oils include the incorporation and modification of cell membrane structure by (n-3) polyunsaturated fatty acids, their direct effect on calcium channels and cardiomyocytes and their role in eicosanoid metabolism. Other mechanisms that are currently being investigated include the role of (n-3) polyunsaturated fatty acids in cell signalling mediated through phosphoinositides and their effect on various enzymes and receptors. This article reviews these mechanisms and the antiarrhythmic studies using (n-3) polyunsaturated fatty acids.
Key words: (n-3) fatty acids, cardiac arrhythmia, electrophysiology, cardiovascular disease, humans, dogs, rats, marmoset monkeys.
This article has been cited by other articles:
|
|
 |
|
  N. Kandasamy, F. Joseph, and N. Goenka Review: The role of omega-3 fatty acids in cardiovascular disease, hypertriglyceridaemia and diabetes mellitus The British Journal of Diabetes & Vascular Disease, May 1, 2008; 8(3): 121 - 126. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Cherian Metabolic and Cardiovascular Diseases in Poultry: Role of Dietary Lipids Poult. Sci., May 1, 2007; 86(5): 1012 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. A. Liou, D. J. King, D. Zibrik, and S. M. Innis Decreasing Linoleic Acid with Constant {alpha}-Linolenic Acid in Dietary Fats Increases (n-3) Eicosapentaenoic Acid in Plasma Phospholipids in Healthy Men J. Nutr., April 1, 2007; 137(4): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chatelier, N. Imbert, J. L. Z. Infante, D. J. McKenzie, and P. Bois Effects of oleic acid on the high threshold barium current in seabass Dicentrarchus labrax ventricular myocytes J. Exp. Biol., October 15, 2006; 209(20): 4033 - 4039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Lichtenstein Thematic review series: Patient-Oriented Research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns J. Lipid Res., August 1, 2006; 47(8): 1661 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Wang, W. S Harris, M. Chung, A. H Lichtenstein, E. M Balk, B. Kupelnick, H. S Jordan, and J. Lau n-3 Fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review Am. J. Clinical Nutrition, July 1, 2006; 84(1): 5 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Deckelbaum, T. S Worgall, and T. Seo n-3 Fatty acids and gene expression Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1520 - 1525S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lopez-Garcia, M. B. Schulze, J. E. Manson, J. B. Meigs, C. M. Albert, N. Rifai, W. C. Willett, and F. B. Hu Consumption of (n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in Women J. Nutr., July 1, 2004; 134(7): 1806 - 1811. [Abstract] [Full Text]
|
|
|
|
 |
|
 K.W. Lee and G.Y.H. Lip The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease QJM, July 1, 2003; 96(7): 465 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Pawlosky, J. R Hibbeln, Y. Lin, S. Goodson, P. Riggs, N. Sebring, G. L Brown, and N. Salem Jr Effects of beef- and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects Am. J. Clinical Nutrition, March 1, 2003; 77(3): 565 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Smuts, M. Huang, D. Mundy, T. Plasse, S. Major, and S. E. Carlson A Randomized Trial of Docosahexaenoic Acid Supplementation During the Third Trimester of Pregnancy Obstet. Gynecol., March 1, 2003; 101(3): 469 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Cheuvront The Zone Diet Phenomenon: A Closer Look at the Science behind the Claims J. Am. Coll. Nutr., February 1, 2003; 22(1): 9 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Ferrier, I. Redondo, J. Zhu, and M. G. Murphy Differential effects of docosahexaenoic acid on contractions and L-type Ca2+ current in adult cardiac myocytes Cardiovasc Res, June 1, 2002; 54(3): 601 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Albert, H. Campos, M. J. Stampfer, P. M. Ridker, J. E. Manson, W. C. Willett, and J. Ma Blood Levels of Long-Chain n-3 Fatty Acids and the Risk of Sudden Death N. Engl. J. Med., April 11, 2002; 346(15): 1113 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Hu, L. Bronner, W. C. Willett, M. J. Stampfer, K. M. Rexrode, C. M. Albert, D. Hunter, and J. E. Manson Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women JAMA, April 10, 2002; 287(14): 1815 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Schmitz and K. A. Antony {omega}-3 fatty acids in ESRD: should patients with ESRD eat more fish? Nephrol. Dial. Transplant., January 1, 2002; 17(1): 11 - 14. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Pawlosky, J. R. Hibbeln, J. A. Novotny, and N. Salem Jr. Physiological compartmental analysis of {alpha}-linolenic acid metabolism in adult humans J. Lipid Res., August 1, 2001; 42(8): 1257 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G.D. Allen and M. A. Harris The Role of n-3 Fatty Acids in Gestation and Parturition Experimental Biology and Medicine, June 1, 2001; 226(6): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.E.M. Lands Biochemistry and physiology of eicosanoid precursors in cell membranes Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D22 - D25. [Abstract] [PDF]
|
|
|
|
 |
|
 J. H. Christensen, H. A. Skou, L. Fog, V. E. Hansen, T. Vesterlund, J. Dyerberg, E. Toft, and E. B. Schmidt Marine n-3 Fatty Acids, Wine Intake, and Heart Rate Variability in Patients Referred for Coronary Angiography Circulation, February 6, 2001; 103(5): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. B. Hu, J. E. Manson, and W. C. Willett Types of Dietary Fat and Risk of Coronary Heart Disease: A Critical Review J. Am. Coll. Nutr., February 1, 2001; 20(1): 5 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J Messina Legumes and soybeans: overview of their nutritional profiles and health effects Am. J. Clinical Nutrition, September 1, 1999; 70(3): 439S - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. D. Nair, J. Leitch, J. Falconer, and M. L Garg Cardiac (n-3) Non-Esterified Fatty Acids Are Selectively Increased in Fish Oil-Fed Pigs following Myocardial Ischemia J. Nutr., August 1, 1999; 129(8): 1518 - 1523. [Abstract] [Full Text]
|
|
|
|
|
|
F. B Hu, M. J Stampfer, J. E Manson, E. B Rimm, A. Wolk, G. A Colditz, C. H Hennekens, and W. C Willett Dietary intake of {alpha}-linolenic acid and risk of fatal ischemic heart disease among women Am. J. Clinical Nutrition, May 1, 1999; 69(5): 890 - 897. [Abstract] [Full Text] [PDF]
|
|
